bg
A

Allovir (ALVR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allovir (ALVR)

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more

  • USD0.77
  • USD0.79
  • USD0.77
  • USD6.12
  • 5.10%
  • --
  • 147.47k
  • 566.36k
  • 86M
  • 0.62
  • -79.50%

Stock News

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App